image

Point of Care Lipid Test Market Report Scope & Overview:

The Point of Care Lipid Test Market size was estimated USD 308.11 million in 2023 and is expected to reach USD 421.67 million by 2031 at a CAGR of 4% during the forecast period of 2024-2031. 

Point of care lipid test are medical tests that help in the diagnosis of a condition in the human body at a precise moment. The point of care testing help to provide real-time results in minutes. As a result, a point of care (POC) lipid test is conducted to evaluate the lipid's activity in the cells. When cholesterol levels rise, the body's lipid function is disrupted, leading to significant ailments such as heart attack and coronary artery disease.

Point of Care Lipid Test Market Revenue Analysis

Get More Information on Point of Care Lipid Test Market - Request Sample Report

MARKET DYNAMICS

DRIVERS

  • A point-of-care (PoC) cholesterol test is gaining interest in the treatment of liver and kidney disorders.

Rising cases of chronic diseases such as liver and kidney disorders, as well as diabetes, are likely to drive the global point of care (PoC) lipid test market during the forecast period. Cardiovascular disease (CVD) is the major cause of death in chronic renal disease patients. One of the most prominent pathophysiological causes for CVD in CKD patients is the widespread and probably enhanced production of atherosclerotic plaques due to hyperlipidemia, uremic toxins, inflammation, and endothelial dysfunction. Chronic kidney disease (CKD) affects more than one out of every seven adults in the United States, or over 37 million people, according to the US Department of Health and Human Services. These are the variables that drive market expansion.

RESTRAINT

  • In some regions, there are no reimbursement policies for POC lipid tests.

  • In emerging economies, product availability is limited.

  • Issues with quality control linked with POC lipid testing devices.

OPPORTUNITY 

  • Partnerships between diagnostic businesses and healthcare providers for efficient point-of-care testing.

  • Creation of novel POC lipid test technology with expanded capabilities.

  • Increasing need for technological advances

Rising need for technical developments that improve speed, accuracy, and usability, as well as rising market penetration rates for technologies such as self-testing handheld devices, are likely to fuel demand. Polymer Technology Systems Inc., for example, developed the CardioChek Plus analyzer in 2013, an upgraded version of their point-of-care multi-analyte device. Sedentary and unhealthy lifestyle choices are likely to supply manufacturers with a growing customer base.

CHALLENGES

  • High price

The rising cost of point-of-care (POC) cholesterol diagnostics will restrain market expansion. It has an additional cost of $2500.00. Furthermore, a lack of lab services in rural areas, particularly in developing countries, would stymie market growth. The scarcity of trained personnel in these domains would further hinder market growth prospects.

IMPACT OF RUSSIAN UKRAINE WAR

The war has significantly increased psychological pain and distress. According to health care professionals around the country, the most common request right now is for help with sleeplessness, anxiety, mourning, and psychological distress. WHO has increased staff and repurposed infrastructure, particularly the logistics system, in response to changing health demands in Ukraine. This has allowed for the delivery of over 543 metric tonnes of medical supplies and equipment to the country, which are being distributed mostly in the east, south, and northern oblasts where the need is highest. Among the materials sent are trauma surgical supplies, ambulances, Ukrainian-made ventilators that can continue to work even when power is down, electric generators, and oxygen equipment, including the construction of oxygen plants.

IMPACT OF ONGOING RECESSION

Three years after the pandemic immobilized the world, its aftermath continues to send the world into a frenzy as the recession siren becomes louder with each passing day. Several businesses, particularly scientific research, are concerned about the current recession warning. The pandemic has reduced the number of new programs and shifted financing to virology and vaccine development. This has a negative impact on research outside of the field of virology and life sciences in general. With several countries in recession, economists forecast a slight recession this year as economic uncertainty grows. Despite the promise of a surge in research funding in 2023, the scientific community is concerned about the consequences of the recession on research financing.

KEY SEGMENTS

By Product Type

  • Devices

  • Consumables

By Application

  • Endogenous Hyperlipemia

  • Combined Hyperlipidemia

  • Familial Hypercholesterolemia

  • Others

By End User

  • Hospitals and Clinics

  • Diagnostic Laboratories

  • Others

REGIONAL ANALYSES

North America held a significant market share in 2023 due to Rising R&D investments and brisk private funding for healthcare infrastructure development are propelling the industry forward. Furthermore, various market competitors are concentrating on developing testing solutions that will provide early results, thereby improving the regional market picture. In May 2023, Sensible Diagnostics, a Los Angeles-based startup, produced a tiny, low-cost sample-to-answer system that can do PCR in 10 minutes, along with economical test cartridges, with the initial focus on infectious disease testing at the point of care.

Asia-Pacific is witness to expand fastest CAGR rate during the forecast period owing to the region's aging population and the increased need for point-of-care testing devices for patients. Furthermore, the region's rising chronic illness burden, combined with the increased emphasis of significant corporations in emerging markets such as China, Japan, and others, is increasing demand for and adoption of point-of-care (PoC) cholesterol test devices.

Point-of-Care-Lipid-Test-Market-By-Region

Get Customized Report as per Your Business Requirement - Request For Customized Report

REGIONAL COVERAGE

North America

  • US

  • Canada

  • Mexico

Europe

  • Eastern Europe

    • Poland

    • Romania

    • Hungary

    • Turkey

    • Rest of Eastern Europe

  • Western Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Netherlands

    • Switzerland

    • Austria

    • Rest of Western Europe

Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Vietnam

  • Singapore

  • Australia

  • Rest of Asia Pacific

Middle East & Africa

  • Middle East

    • UAE

    • Egypt

    • Saudi Arabia

    • Qatar

    • Rest of Middle East

  • Africa

    • Nigeria

    • South Africa

    • Rest of Africa

Latin America

  • Brazil

  • Argentina

  • Colombia

  • Rest of Latin America

Key Players

The major key players are Abbott Laboratories,Nova Biomedical Corporation, Menarini Group, Sinocare Inc.,Zoetis Inc.,Callegari, VivaChek Biotech (Hangzhou) Co.,Ltd, F. Hoffmann-La Roche Ltd,Biosensor,Inc., Mico Bio Med and Others.

Vital Biosciences-Company Financial Analysis

Company Landscape Analysis

RECENT DEVELOPMENT

In July 2023, Vital Biosciences introduced VitalOne, a new point-of-care lab testing technology that allows clinicians to conduct tests, diagnose patients, and treat them all in a single visit.

In January 2022, in regions where the CE Mark is accepted, Roche launched the Cobas pulse system, which combines professional blood glucose control with mobile digital medical capabilities to improve patient care.

Point of Care Lipid Test Market Report Scope:
Report Attributes Details
Market Size in 2023  US$ 308.11 million
Market Size by 2031  US$ 421.67 million
CAGR   CAGR of 4% From 2024 to 2031
Base Year 2023
Forecast Period  2024-2031
Historical Data  2020-2022
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments By Product Type [Devices, Consumables],By Application [Endogenous Hyperlipemia, Combined Hyperlipidemia, Familial Hypercholesterolemia, Others],By End User [Hospitals and Clinics, Diagnostic Laboratories, Others]
Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)
Company Profiles Abbott Laboratories,Nova Biomedical Corporation, Menarini Group, Sinocare Inc.,Zoetis Inc.,Callegari, VivaChek Biotech (Hangzhou) Co.,Ltd, F. Hoffmann-La Roche Ltd,Biosensor,Inc., Mico Bio Med
Key Drivers • A point-of-care (PoC) cholesterol test is gaining interest in the treatment of liver and kidney disorders.
Market Restrain • In some regions, there are no reimbursement policies for POC lipid tests.
• In emerging economies, product availability is limited.
• Issues with quality control linked with POC lipid testing devices.

 

Frequently Asked Questions

Ans: Point of Care Lipid Test Market is anticipated to expand by 4% from 2024 to 2031.

Ans:  The expected growth rate of Care Lipid Test Market is USD 421.67 million by 2031.

Ans: Point of Care Lipid Test Market size was valued at USD 308.11 million in 2023.

Ans: North America is dominating the market of Point of Care Lipid Test Market.

Ans: Partnerships between diagnostic businesses and healthcare providers for efficient point-of-care testing.

TABLE OF CONTENTS

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

2. Industry Flowchart

3. Research Methodology

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

5. Impact Analysis

5.1 Impact of Russia-Ukraine Crisis

5.2 Impact of Economic Slowdown on Major Countries

5.2.1 Introduction

5.2.2 United States

5.2.3 Canada

5.2.4 Germany

5.2.5 France

5.2.6 UK

5.2.7 China

5.2.8 Japan

5.2.9 South Korea

5.2.10 India

6. Value Chain Analysis

7. Porter’s 5 Forces Model

8. Pest Analysis

9. Point of Care Lipid Test Market Segmentation, By Product Type

9.1 Introduction

    1. Trend Analysis

9.3 Devices

9.4 Consumables

10. Point of Care Lipid Test Market Segmentation, By Application

    1. Introduction

10.2 Trend Analysis

10.3 Endogenous Hyperlipemia

10.4 Combined Hyperlipidemia

10.5 Familial Hypercholesterolemia

    1. Others

11. Point of Care Lipid Test Market Segmentation, By End User

11.1 Introduction

    1. Trend Analysis

11.3 Hospitals and Clinics

11.4 Diagnostic Laboratories

11.5 Others

12. Regional Analysis

12.1 Introduction

12.2 North America

12.2.1 Trend Analysis

12.2.2 North America Point of Care Lipid Test Market by Country

12.2.3 North America Point of Care Lipid Test Market By Product Type

12.2.4 North America Point of Care Lipid Test Market By Application

12.2.5 North America Point of Care Lipid Test Market By End User

12.2.6 USA

12.2.6.1 USA Point of Care Lipid Test Market By Product Type

12.2.6.2 USA Point of Care Lipid Test Market By Application

12.2.6.3 USA Point of Care Lipid Test Market By End User

12.2.7 Canada

12.2.7.1 Canada Point of Care Lipid Test Market By Product Type

12.2.7.2 Canada Point of Care Lipid Test Market By Application

12.2.7.3 Canada Point of Care Lipid Test Market By End User

12.2.8 Mexico

12.2.8.1 Mexico Point of Care Lipid Test Market By Product Type

12.2.8.2 Mexico Point of Care Lipid Test Market By Application

12.2.8.3 Mexico Point of Care Lipid Test Market By End User

12.3 Europe

12.3.1 Trend Analysis

12.3.2 Eastern Europe

12.3.2.1 Eastern Europe Point of Care Lipid Test Market by Country

12.3.2.2 Eastern Europe Point of Care Lipid Test Market By Product Type

12.3.2.3 Eastern Europe Point of Care Lipid Test Market By Application

12.3.2.4 Eastern Europe Point of Care Lipid Test Market By End User

12.3.2.5 Poland

12.3.2.5.1 Poland Point of Care Lipid Test Market By Product Type

12.3.2.5.2 Poland Point of Care Lipid Test Market By Application

12.3.2.5.3 Poland Point of Care Lipid Test Market By End User

12.3.2.6 Romania

12.3.2.6.1 Romania Point of Care Lipid Test Market By Product Type

12.3.2.6.2 Romania Point of Care Lipid Test Market By Application

12.3.2.6.4 Romania Point of Care Lipid Test Market By End User

12.3.2.7 Hungary

12.3.2.7.1 Hungary Point of Care Lipid Test Market By Product Type

12.3.2.7.2 Hungary Point of Care Lipid Test Market By Application

12.3.2.7.3 Hungary Point of Care Lipid Test Market By End User

12.3.2.8 Turkey

12.3.2.8.1 Turkey Point of Care Lipid Test Market By Product Type

12.3.2.8.2 Turkey Point of Care Lipid Test Market By Application

12.3.2.8.3 Turkey Point of Care Lipid Test Market By End User

12.3.2.9 Rest of Eastern Europe

12.3.2.9.1 Rest of Eastern Europe Point of Care Lipid Test Market By Product Type

12.3.2.9.2 Rest of Eastern Europe Point of Care Lipid Test Market By Application

12.3.2.9.3 Rest of Eastern Europe Point of Care Lipid Test Market By End User

12.3.3 Western Europe

12.3.3.1 Western Europe Point of Care Lipid Test Market by Country

12.3.3.2 Western Europe Point of Care Lipid Test Market By Product Type

12.3.3.3 Western Europe Point of Care Lipid Test Market By Application

12.3.3.4 Western Europe Point of Care Lipid Test Market By End User

12.3.3.5 Germany

12.3.3.5.1 Germany Point of Care Lipid Test Market By Product Type

12.3.3.5.2 Germany Point of Care Lipid Test Market By Application

12.3.3.5.3 Germany Point of Care Lipid Test Market By End User

12.3.3.6 France

12.3.3.6.1 France Point of Care Lipid Test Market By Product Type

12.3.3.6.2 France Point of Care Lipid Test Market By Application

12.3.3.6.3 France Point of Care Lipid Test Market By End User

12.3.3.7 UK

12.3.3.7.1 UK Point of Care Lipid Test Market By Product Type

12.3.3.7.2 UK Point of Care Lipid Test Market By Application

12.3.3.7.3 UK Point of Care Lipid Test Market By End User

12.3.3.8 Italy

12.3.3.8.1 Italy Point of Care Lipid Test Market By Product Type

12.3.3.8.2 Italy Point of Care Lipid Test Market By Application

12.3.3.8.3 Italy Point of Care Lipid Test Market By End User

12.3.3.9 Spain

12.3.3.9.1 Spain Point of Care Lipid Test Market By Product Type

12.3.3.9.2 Spain Point of Care Lipid Test Market By Application

12.3.3.9.3 Spain Point of Care Lipid Test Market By End User

12.3.3.10 Netherlands

12.3.3.10.1 Netherlands Point of Care Lipid Test Market By Product Type

12.3.3.10.2 Netherlands Point of Care Lipid Test Market By Application

12.3.3.10.3 Netherlands Point of Care Lipid Test Market By End User

12.3.3.11 Switzerland

12.3.3.11.1 Switzerland Point of Care Lipid Test Market By Product Type

12.3.3.11.2 Switzerland Point of Care Lipid Test Market By Application

12.3.3.11.3 Switzerland Point of Care Lipid Test Market By End User

12.3.3.1.12 Austria

12.3.3.12.1 Austria Point of Care Lipid Test Market By Product Type

12.3.3.12.2 Austria Point of Care Lipid Test Market By Application

12.3.3.12.3 Austria Point of Care Lipid Test Market By End User

12.3.3.13 Rest of Western Europe

12.3.3.13.1 Rest of Western Europe Point of Care Lipid Test Market By Product Type

12.3.3.13.2 Rest of Western Europe Point of Care Lipid Test Market By Application

12.3.3.13.3 Rest of Western Europe Point of Care Lipid Test Market By End User

12.4 Asia-Pacific

12.4.1 Trend Analysis

12.4.2 Asia-Pacific Point of Care Lipid Test Market by Country

12.4.3 Asia-Pacific Point of Care Lipid Test Market By Product Type

12.4.4 Asia-Pacific Point of Care Lipid Test Market By Application

12.4.5 Asia-Pacific Point of Care Lipid Test Market By End User

12.4.6 China

12.4.6.1 China Point of Care Lipid Test Market By Product Type

12.4.6.2 China Point of Care Lipid Test Market By Application

12.4.6.3 China Point of Care Lipid Test Market By End User

12.4.7 India

12.4.7.1 India Point of Care Lipid Test Market By Product Type

12.4.7.2 India Point of Care Lipid Test Market By Application

12.4.7.3 India Point of Care Lipid Test Market By End User

12.4.8 Japan

12.4.8.1 Japan Point of Care Lipid Test Market By Product Type

12.4.8.2 Japan Point of Care Lipid Test Market By Application

12.4.8.3 Japan Point of Care Lipid Test Market By End User

12.4.9 South Korea

12.4.9.1 South Korea Point of Care Lipid Test Market By Product Type

12.4.9.2 South Korea Point of Care Lipid Test Market By Application

12.4.9.3 South Korea Point of Care Lipid Test Market By End User

12.4.10 Vietnam

12.4.10.1 Vietnam Point of Care Lipid Test Market By Product Type

12.4.10.2 Vietnam Point of Care Lipid Test Market By Application

12.4.10.3 Vietnam Point of Care Lipid Test Market By End User

12.4.11 Singapore

12.4.11.1 Singapore Point of Care Lipid Test Market By Product Type

12.4.11.2 Singapore Point of Care Lipid Test Market By Application

12.4.11.3 Singapore Point of Care Lipid Test Market By End User

12.4.12 Australia

12.4.12.1 Australia Point of Care Lipid Test Market By Product Type

12.4.12.2 Australia Point of Care Lipid Test Market By Application

12.4.12.3 Australia Point of Care Lipid Test Market By End User

12.4.13 Rest of Asia-Pacific

12.4.13.1 Rest of Asia-Pacific Point of Care Lipid Test Market By Product Type

12.4.13.2 Rest of Asia-Pacific Point of Care Lipid Test Market By Application

12.4.13.3 Rest of Asia-Pacific Point of Care Lipid Test Market By End User

12.5 Middle East & Africa

12.5.1 Trend Analysis

12.5.2 Middle East

12.5.2.1 Middle East Point of Care Lipid Test Market by Country

12.5.2.2 Middle East Point of Care Lipid Test Market By Product Type

12.5.2.3 Middle East Point of Care Lipid Test Market By Application

12.5.2.4 Middle East Point of Care Lipid Test Market By End User

12.5.2.5 UAE

12.5.2.5.1 UAE Point of Care Lipid Test Market By Product Type

12.5.2.5.2 UAE Point of Care Lipid Test Market By Application

12.5.2.5.3 UAE Point of Care Lipid Test Market By End User

12.5.2.6 Egypt

12.5.2.6.1 Egypt Point of Care Lipid Test Market By Product Type

12.5.2.6.2 Egypt Point of Care Lipid Test Market By Application

12.5.2.6.3 Egypt Point of Care Lipid Test Market By End User

12.5.2.7 Saudi Arabia

12.5.2.7.1 Saudi Arabia Point of Care Lipid Test Market By Product Type

12.5.2.7.2 Saudi Arabia Point of Care Lipid Test Market By Application

12.5.2.7.3 Saudi Arabia Point of Care Lipid Test Market By End User

12.5.2.8 Qatar

12.5.2.8.1 Qatar Point of Care Lipid Test Market By Product Type

12.5.2.8.2 Qatar Point of Care Lipid Test Market By Application

12.5.2.8.3 Qatar Point of Care Lipid Test Market By End User

12.5.2.9 Rest of Middle East

12.5.2.9.1 Rest of Middle East Point of Care Lipid Test Market By Product Type

12.5.2.9.2 Rest of Middle East Point of Care Lipid Test Market By Application

12.5.2.9.3 Rest of Middle East Point of Care Lipid Test Market By End User

12.5.3 Africa

12.5.3.1 Africa Point of Care Lipid Test Market by Country

12.5.3.2 Africa Point of Care Lipid Test Market By Product Type

12.5.3.3 Africa Point of Care Lipid Test Market By Application

12.5.3.4 Africa Point of Care Lipid Test Market By End User

12.5.3.5 Nigeria

12.5.3.5.1 Nigeria Point of Care Lipid Test Market By Product Type

12.5.3.5.2 Nigeria Point of Care Lipid Test Market By Application

12.5.3.5.3 Nigeria Point of Care Lipid Test Market By End User

12.5.3.6 South Africa

12.5.3.6.1 South Africa Point of Care Lipid Test Market By Product Type

12.5.3.6.2 South Africa Point of Care Lipid Test Market By Application

12.5.3.6.3 South Africa Point of Care Lipid Test Market By End User

12.5.3.7 Rest of Africa

12.5.3.7.1 Rest of Africa Point of Care Lipid Test Market By Product Type

12.5.3.7.2 Rest of Africa Point of Care Lipid Test Market By Application

12.5.3.7.3 Rest of Africa Point of Care Lipid Test Market By End User

12.6 Latin America

12.6.1 Trend Analysis

12.6.2 Latin America Point of Care Lipid Test Market by country

12.6.3 Latin America Point of Care Lipid Test Market By Product Type

12.6.4 Latin America Point of Care Lipid Test Market By Application

12.6.5 Latin America Point of Care Lipid Test Market By End User

12.6.6 Brazil

12.6.6.1 Brazil Point of Care Lipid Test Market By Product Type

12.6.6.2 Brazil Point of Care Lipid Test Market By Application

12.6.6.3 Brazil Point of Care Lipid Test Market By End User

12.6.7 Argentina

12.6.7.1 Argentina Point of Care Lipid Test Market By Product Type

12.6.7.2 Argentina Point of Care Lipid Test Market By Application

12.6.7.3 Argentina Point of Care Lipid Test Market By End User

12.6.8 Colombia

12.6.8.1 Colombia Point of Care Lipid Test Market By Product Type

12.6.8.2 Colombia Point of Care Lipid Test Market By Application

12.6.8.3 Colombia Point of Care Lipid Test Market By End User

12.6.9 Rest of Latin America

12.6.9.1 Rest of Latin America Point of Care Lipid Test Market By Product Type

12.6.9.2 Rest of Latin America Point of Care Lipid Test Market By Application

12.6.9.3 Rest of Latin America Point of Care Lipid Test Market By End User

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Company Overview

13.1.2 Financial

13.1.3 Product Type / Services Offered

13.1.4 SWOT Analysis

13.1.5 The SNS View

13.2 Nova Biomedical Corporation

13.2.1 Company Overview

13.2.2 Financial

13.2.3 Product Type / Services Offered

13.2.4 SWOT Analysis

13.2.5 The SNS View

13.3 Menarini Group

13.3.1 Company Overview

13.3.2 Financial

13.3.3 Product Type / Services Offered

13.3.4 SWOT Analysis

13.3.5 The SNS View

13.4 Sinocare Inc.

13.4.1 Company Overview

13.4.2 Financial

13.4.3 Product Type / Services Offered

13.4.4 SWOT Analysis

13.4.5 The SNS View

13.5 Zoetis Inc.

13.5.1 Company Overview

13.5.2 Financial

13.5.3 Product Type / Services Offered

13.5.4 SWOT Analysis

13.5.5 The SNS View

13.6 Callegari

13.6.1 Company Overview

13.6.2 Financial

13.6.3 Product Type / Services Offered

13.6.4 SWOT Analysis

13.6.5 The SNS View

13.7 VivaChek Biotech (Hangzhou) Co. Ltd

13.7.1 Company Overview

13.7.2 Financial

13.7.3 Product Type / Services Offered

13.7.4 SWOT Analysis

13.7.5 The SNS View

13.8 F. Hoffmann-La Roche Ltd

13.8.1 Company Overview

13.8.2 Financial

13.8.3 Product Type / Services Offered

13.8.4 SWOT Analysis

13.8.5 The SNS View

13.9 Biosensor,Inc.

13.9.1 Company Overview

13.9.2 Financial

13.9.3 Product Type / Services Offered

13.9.4 SWOT Analysis

13.9.5 The SNS View

13.10   Mico Bio Med

13.10.1 Company Overview

13.10.2 Financial

13.10.3 Product Type / Services Offered

13.10.4 SWOT Analysis

13.10.5 The SNS View

14. Competitive Landscape

14.1 Competitive Benchmarking

14.2 Market Share Analysis

14.3 Recent Developments

14.3.1 Industry News

14.3.2 Company News

14.3.3 Mergers & Acquisitions

15. Use Case and Best Practices

16. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

 

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone